These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34440487)
21. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo. Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675 [TBL] [Abstract][Full Text] [Related]
22. The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach. Mostafa F; Mantawy EM; Azab SS; El-Demerdash E Eur J Pharmacol; 2019 Dec; 865():172729. PubMed ID: 31605676 [TBL] [Abstract][Full Text] [Related]
24. Bee venom suppresses testosterone-induced benign prostatic hyperplasia by regulating the inflammatory response and apoptosis. Chung KS; An HJ; Cheon SY; Kwon KR; Lee KH Exp Biol Med (Maywood); 2015 Dec; 240(12):1656-63. PubMed ID: 26085572 [TBL] [Abstract][Full Text] [Related]
25. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia. Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993 [TBL] [Abstract][Full Text] [Related]
26. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Kayode OT; Owolabi AV; Kayode AAA Biomed Pharmacother; 2020 Dec; 132():110863. PubMed ID: 33113424 [TBL] [Abstract][Full Text] [Related]
27. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study]. Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195 [TBL] [Abstract][Full Text] [Related]
29. Protective role of diosmin against testosterone propionate-induced prostatic hyperplasia in Wistar rats: Plausible role of oxidative stress and inflammation. Vafa A; Afzal SM; Barnwal P; Rashid S; Shahid A; Alpashree ; Islam J; Sultana S Hum Exp Toxicol; 2020 Sep; 39(9):1133-1146. PubMed ID: 31797688 [TBL] [Abstract][Full Text] [Related]
30. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2. Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799 [TBL] [Abstract][Full Text] [Related]
31. Extracts of Song KH; Seo CS; Yang WK; Gu HO; Kim KJ; Kim SH Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803357 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory Effect of Thymoquinone on Testosterone-Induced Benign Prostatic Hyperplasia in Wistar Rats. Al-Trad B; Al-Zoubi M; Qar J; Al-Batayneh K; Hussien E; Muhaidat R; Aljabali A; Alkhateeb H; Al Omari G Phytother Res; 2017 Dec; 31(12):1910-1915. PubMed ID: 28960541 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of diosgenin on experimentally induced benign prostatic hyperplasia in rats. Chen J; Zhang HF; Xiong CM; Ruan JL J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):806-810. PubMed ID: 27924509 [TBL] [Abstract][Full Text] [Related]
35. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis. Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623 [TBL] [Abstract][Full Text] [Related]
36. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase. Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726 [TBL] [Abstract][Full Text] [Related]
37. Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats. Hwangbo H; Kwon DH; Choi EO; Kim MY; Ahn KI; Ji SY; Kim JS; Kim KI; Park NJ; Kim BH; Kim GY; Hong SH; Park C; Jeong JS; Choi YH Nutr Res Pract; 2018 Oct; 12(5):378-386. PubMed ID: 30323905 [TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats. Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338 [TBL] [Abstract][Full Text] [Related]
39. Palmitoylethanolamide/Baicalein Regulates the Androgen Receptor Signaling and NF-κB/Nrf2 Pathways in Benign Prostatic Hyperplasia. D'Amico R; Genovese T; Cordaro M; Siracusa R; Gugliandolo E; Peritore AF; Interdonato L; Crupi R; Cuzzocrea S; Di Paola R; Fusco R; Impellizzeri D Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34202665 [TBL] [Abstract][Full Text] [Related]
40. Protocatechuic acid ameliorates testosterone-induced benign prostatic hyperplasia through the regulation of inflammation and oxidative stress in castrated rats. Akanni OO; Owumi SE; Olowofela OG; Adeyanju AA; Abiola OJ; Adaramoye OA J Biochem Mol Toxicol; 2020 Aug; 34(8):e22502. PubMed ID: 32227675 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]